![Kidney disease trials for the 21st century: innovations in design and conduct | Nature Reviews Nephrology Kidney disease trials for the 21st century: innovations in design and conduct | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41581-019-0212-x/MediaObjects/41581_2019_212_Fig1_HTML.png)
Kidney disease trials for the 21st century: innovations in design and conduct | Nature Reviews Nephrology
![Leading Hackensack Meridian Children's Health Nephrologists Are Principal Investigators in Clinical Trial of New Medication to Treat Children with Rare Kidney Diseases Leading Hackensack Meridian Children's Health Nephrologists Are Principal Investigators in Clinical Trial of New Medication to Treat Children with Rare Kidney Diseases](https://www.hackensackmeridianhealth.org/-/media/Project/HMH/HMH/Public/US-News-2022/Pediatric-Nephrology/Rare-Kidney-Disease-1200-600.jpg)
Leading Hackensack Meridian Children's Health Nephrologists Are Principal Investigators in Clinical Trial of New Medication to Treat Children with Rare Kidney Diseases
![International consensus definitions of clinical trial outcomes for kidney failure: 2020 - Kidney International International consensus definitions of clinical trial outcomes for kidney failure: 2020 - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9594688e-bfb2-46ea-a50e-8b79bbb18347/gr1_lrg.jpg)
International consensus definitions of clinical trial outcomes for kidney failure: 2020 - Kidney International
Kidney Health Initiative Project Explores Cardiovascular Clinical Trials for People with Kidney Diseases in: Kidney News Volume 10 Issue 4 (2018)
![Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference - American Journal of Kidney Diseases Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference - American Journal of Kidney Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b4ae3cae-d35e-4741-9a3d-56b9f40f48e6/gr1_lrg.jpg)
Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference - American Journal of Kidney Diseases
![UAB announces first clinical-grade transplant of gene-edited pig kidneys into brain-dead human - News | UAB UAB announces first clinical-grade transplant of gene-edited pig kidneys into brain-dead human - News | UAB](https://www.uab.edu/news/images/2018/02_UAB_achieves_Worlds_First_infographic.LARGE.jpg)
UAB announces first clinical-grade transplant of gene-edited pig kidneys into brain-dead human - News | UAB
![Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/73f2df0d-0edd-4eba-a066-3225d572b5a7/gr1.jpg)
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology
![Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials - The Lancet Diabetes & Endocrinology Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/abba3778-7ea2-4927-a842-7aca2c8f5766/gr1_lrg.gif)
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials - The Lancet Diabetes & Endocrinology
![Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials - The Lancet Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cb6fe61d-48a1-4e8e-bcb8-1e39e81a99a4/gr1_lrg.jpg)